JUST one tablet of paracetamol (acetaminophen) could help save earthquake survivors who otherwise risk dying from kidney failure after rescue. Experiments in rats have shown that the drug prevents 鈥渃rush syndrome鈥�, or , in which muscle debris from crushed limbs floods the kidneys soon after the limb is freed from rubble, causing them to fail.
鈥淲hen you release the pressure on muscle through rescue, debris goes to the kidney. It鈥檚 like a chain reaction, and acetaminophen blocks it,鈥� says of Vanderbilt University in Nashville, Tennessee, and head of the research team.
The destruction of muscle through crushing leads to the release of myoglobin, a protein vital for delivering oxygen to muscle and other tissue. When the myoglobin reaches the kidneys it clogs the tubules and produces harmful chemical agents called free radicals.
Advertisement
These free radicals destroy fatty membranes in the kidney, which die and turn black. They also trigger constriction of blood vessels, cutting off blood flow to the kidney and halting filtration of blood, rapidly leading to death through kidney failure. The condition became known as the 鈥渟miling death鈥� in China after apparently uninjured victims died.
After inducing crush syndrome in rats via muscular injections of sugar, Boutaud and colleagues demonstrated that the human-equivalent dose of acetaminophen successfully blocked both of these processes, whether given before or shortly after the injury (Proceedings of the National Academy of Sciences, ).
Although the finding has come too late to save lives following the quake in Haiti, Boutaud is hopeful that the treatment can be validated in humans before, or even during, the next big quake. 鈥淲e don鈥檛 know yet whether it would work, or how soon we鈥檇 need to give it to prevent kidney damage,鈥� he says, 鈥渂ut we must try because it could save thousands of lives.鈥�
鈥淲e don鈥檛 know whether it would work, but we must try because it could save thousands of lives鈥�
Martin de Smet of will refer Boutaud鈥檚 results to the 鈥荣 , which has developed validated protocols for treating crush-syndrome victims, involving the rapid infusion of saline fluids. The drug might be testable as a supportive treatment, he says.
